Posts

Meet ECT at the 16th International Waste Management and Landfill Symposium

The 16th International Waste Management and Landfill Symposium takes place in Forte Village, Santa Margherita di Pula (Sardinia, Italy) from 2 to 6 October 2017. ECT is contributing with the following platform presentation: J. Römbke: Testing of 24 potentially hazardous wastes using ecotoxicological tests For further information on the International Waste Management and Landfill Symposium […]

ECT at the SETAC Latin America 12th Biennial Meeting

The 12th Biennial Meeting of SETAC Latin America (‘Bridging the gap between science and governance’) takes place in Santos, São Paulo, Brazil, from 7 to 10 September 2017. ECT is contributing with the following two platform presentations: J. Römbke, J. Bernard: The TRIAD – a new ISO standard for retrospective risk assessment in soil (ISO […]

Transformation of veterinary pharmaceuticals and biocides in liquid manure

Veterinary medicinal products administered to animals are excreted with urine and faeces. For animals housed in stables, the resulting manure is collected and stored before being spread onto agricultural land. Disinfection products used to sanitize stables are also transferred into the manure. Therefore, the spreading of manure is an important pathway of introducing veterinary medicines, […]

Comparison of the environmental properties of parasiticides and harmonisation of the basis for environmental assessment at the EU level

Avermectin and milbemycin parasiticides have a high toxicity to non-target organisms, are often persistent and may have a potential to bioaccumulate. The present project contributes to filling gaps in the database for a complete environmental risk assessment of these parasiticides. In addition, risk management strategies for parasiticides used in pasture animals were discussed. For ivermectin […]

Development of effective measures to reduce the environmental risk of human and veterinary pharmaceuticals

The environmental risks related to human and veterinary pharmaceuticals have to be assessed according to legal requirements within the authorisation procedures for pharmaceuticals. If a risk for the environment is indicated, risk mitigation measures should be proposed by the applicant and implemented within the risk management. The authorisation of a veterinary pharmaceutical can be refused […]

Investigation of sublethal endpoints in dung organisms as a prerequisite for the implementation of terrestrial ecotoxicological studies within the environmental risk assessment of veterinary pharmaceuticals

The aims of this project were the compilation and publication of the results of workshops with international dung fauna experts (Aveiro group) and the further improvement of existing laboratory tests with dung beetles and dung flies. Two publications were prepared: first, recommendations for the preparation, performance and assessment of field studies with dung organisms, and […]

Environmental risk assessment of veterinary medicines: Are there data gaps and how can the new legal requirement be met?

The most likely entry pathways of veterinary medicinal products (VMPs) into the environment are via slurry or manure from intensively reared animals to soil, and via dung or urine from animals grazing on pasture. Surface water may be contaminated via run-off or leaching and drainage, or  by direct excretion of pasture animals into water. According […]

Environmental risk assessment of pharmaceuticals (ERAPharm)

The widespread detection of a large variety of pharmaceuticals in the environment has raised concern about the potential impact of these bioactive substances on the environment. The overall aim of ERAPharm was to advance existing knowledge and methods for the environmental risk assessment of pharmaceuticals. Within the three years of the project, the impact of […]